RUNX1 and acute myeloid leukemia: For example, mixed-lineage leukemia (MLL) fusions (t(11q23)) and AML1-ETO (t(8;21)), as well as oncogenic proteins HOXA9 and BCL2, facilitate the self-renewal ability and inhibit the apoptosis of AML blasts 4, 5.